Molecular-based carbapenem resistance testing in Gram-negative bacterial bloodstream infections (BSIs) is currently limited because of the reliance on positive blood culture (BC) samples. The T2Resistance™ panel may now allow the detection of carbapenemase-and other β-lactamase encoding genes directly from blood samples. We detected carbapenem resistance genes in 11 (84.6%) of 13 samples from patients with BC-documented BSIs (10 caused by KPC-producing Klebsiella pneumoniae and 1 caused by VIM/CMY-producing Citrobacter freundii). Two samples that tested negative for carbapenem resistance genes were from patients with BC-documented BSIs caused by KPC-producing K. pneumoniae who were receiving effective antibiotic therapy. In conclusion, our findings suggest that the T2Resistance™ panel can be a reliable tool for diagnosing carbapenem-resistant Gram-negative bacterial BSIs.

De Angelis, G., Paggi, R., Lowery, T. J., Snyder, J. L., Menchinelli, G., Sanguinetti, M., Posteraro, B., Mencacci, A., Direct testing for kpc-mediated carbapenem resistance from blood samples using a t2 magnetic resonance based assay, <<ANTIBIOTICS>>, 2022; 10 (8): 950-N/A. [doi:10.3390/antibiotics10080950] [http://hdl.handle.net/10807/198167]

Direct testing for kpc-mediated carbapenem resistance from blood samples using a t2 magnetic resonance based assay

De Angelis, Giulia;Paggi, Raffaela;Menchinelli, Giulia;Sanguinetti, Maurizio;Posteraro, Brunella;
2021

Abstract

Molecular-based carbapenem resistance testing in Gram-negative bacterial bloodstream infections (BSIs) is currently limited because of the reliance on positive blood culture (BC) samples. The T2Resistance™ panel may now allow the detection of carbapenemase-and other β-lactamase encoding genes directly from blood samples. We detected carbapenem resistance genes in 11 (84.6%) of 13 samples from patients with BC-documented BSIs (10 caused by KPC-producing Klebsiella pneumoniae and 1 caused by VIM/CMY-producing Citrobacter freundii). Two samples that tested negative for carbapenem resistance genes were from patients with BC-documented BSIs caused by KPC-producing K. pneumoniae who were receiving effective antibiotic therapy. In conclusion, our findings suggest that the T2Resistance™ panel can be a reliable tool for diagnosing carbapenem-resistant Gram-negative bacterial BSIs.
2021
Inglese
De Angelis, G., Paggi, R., Lowery, T. J., Snyder, J. L., Menchinelli, G., Sanguinetti, M., Posteraro, B., Mencacci, A., Direct testing for kpc-mediated carbapenem resistance from blood samples using a t2 magnetic resonance based assay, <<ANTIBIOTICS>>, 2022; 10 (8): 950-N/A. [doi:10.3390/antibiotics10080950] [http://hdl.handle.net/10807/198167]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10807/198167
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 3
  • ???jsp.display-item.citation.isi??? 4
social impact